Forget About the Pot Party Being Over: Get Rich off the Next Wave of Marijuana IPOs

Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) won’t be the last cannabis IPO to deliver amazing returns.

| More on:
edit Jars of marijuana

Image source: Getty Images

Canadian cannabis cultivators have been some of the hottest stocks to go public during this decade. After its initial public offering (IPO) and then listing on the NYSE, Canada’s leading cannabis cultivator Canopy Growth (TSX:WEED)(NYSE:CGC) is up by over 1,960% since debuting in April 2014 on the TSX and closing at $2.59 per share at writing.

While it’s doubtful that Canopy or any of the major cultivators can generate similar such returns in coming years, the hype surrounding cannabis stocks is far from over.

Legal cannabis demand to grow

What is undeniable, despite the naysayers, is that the legal cannabis industry is here to stay and will continue to grow at a solid clip, with analysts tipping that global sales will expand at a compound annual growth rate (CAGR) of around 24%.

That indicates there are considerable fortunes to be made, but it won’t be by cultivators, instead it will be made by those companies engaged in providing the required technology, biotech and management infrastructure as well as delivery systems.

This is becoming ever clearer even as cannabis cultivators like Canopy are struggling to operate profitably and are in the process of being acquired by established liquor, pharmaceutical and tobacco companies as they branch into the cannabis market.

Constellation Brands owns about a 40% stake in Canopy for a US$4 billion investment, and it appears that the billion-dollar liquor giant could be positioning itself to absorb Canada’s largest marijuana cultivator with co-founder and co-CEO Brue Linton stepping down.

Leading tobacco company Altria made a US$1.8 billion investment in Cronos Group  to acquire a 45% stake, as it moves to reposition itself and enter alternate markets as tobacco sales continue shrinking at a rapid clip. It’s also likely that, because the moat for cultivators is quite narrow, there will be an explosion of marijuana growers once the U.S. federal government legalizes cannabis use in one form or another.

Technology to lead the next round of IPOs

There is every sign that there will be a rush of cannabis technology IPOs in the wake of Akerna, which spiked by nearly 224% one day after listing and has since pulled back sharply as an increasingly negative outlook for the cannabis industry in the wake of Canopy’s disastrous results weighs on marijuana stocks.

One delivery system designer and manufacturer slated for an IPO in 2020 is Pax Labs which designs and manufactures vape delivery systems. Two months ago, it completed a US$420 million equity raising and was valued at US$1.7 billion. Since then it has signed definitive agreements with a range of cultivators including Aphria and Aurora Cannabis to provide cannabis extracts for its delivery systems.

Another cannabis company where there is growing speculation that it will IPO is Cannalife Capital which is focused on developing businesses developing cannabidiol (CBD) products. Earlier this year it announced it had signed a letter of intent to acquire Blue Sky Biologicals, a manufacturer of cannabinoid healthcare and pet care products.

Blue Sky has established the Golden Harvest brand and is developing a suite of pet care, cosmetic and personal care cannabinoid products for launch in Australia, China, Thailand, Japan, Canada, Mexico and the U.S. It has also established global manufacturing practice (GMP) standard pharma grade facilities in China which are producing organic cannabinoid products.

Foolish takeaway

There will be a slew of cannabis IPOs focused on technology, manufacturing and delivery systems over coming months, as the size of the global legal cannabis market becomes apparent and market opportunities are emphasized. The legalization of marijuana extracts, edibles and topicals in Canada on or before October 17, 2019 will create a massive opportunity for all business along the marijuana value chain.

While there are claims that cultivators such as Canopy are incapable of producing enough marijuana to meet existing demand, it will be the growing demand for edibles, delivery devices, medical applications and platforms for managing regulatory compliance which will offer the greatest opportunity.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Matt Smith has no position in any of the stocks mentioned.

More on Cannabis Stocks

Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.
Cannabis Stocks

Canopy Growth: Is There Budding Potential in the Cannabis Market?

Canopy Growth stock hit 52-week lows recently on news of needing to re-file on its BIoSteel business, so what now?

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

What’s Happening With Cannabis Stocks in May 2023?

Cannabis stocks were up this week, as the market began to turn, but how long will it last, and is…

Read more »

Cannabis smoke
Cannabis Stocks

Are Cannabis Stocks a Good Buy in May 2023?

If you're going to buy cannabis stocks, these are pretty much the only two I would consider. Even so, you…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Aurora Cannabis: Time to Light Up Your Portfolio?

Here's my take on whether Aurora Cannabis (TSX:ACB) is worth adding to a growth portfolio right now, given its growth…

Read more »

Target. Stand out from the crowd
Tech Stocks

These Undervalued TSX Stocks Are a Bargain in May 2023

If you're willing to bet on a rebound, these are the three TSX stocks I would consider first as they…

Read more »

A cannabis plant grows.
Cannabis Stocks

Tilray Stock Is Scraping 52-Week Lows: Will it Bottom Out Soon?

Tilray (TSX:TLRY) stock remains down 53% in the last year, but when will this company hit the bottom and start…

Read more »

Medicinal research is conducted on cannabis.
Metals and Mining Stocks

2 Canadian Stocks That Are Simply Too Cheap to Avoid

These two Canadian stocks have sunk lower and lower, which is why now could be the right time for long-term…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

1 Marijuana Stock I’d Buy Over Aurora Cannabis

Explore a promising marijuana stock that outshines Aurora Cannabis. Unveil the investment opportunity to boost your cannabis portfolio.

Read more »